Journals / Journal of the Turkish-German Gynecological Association / 2021 / Cilt: 22 - Sayı: 1

Morcellation in gynecology: short review andsuggestions from Turkish Society of Minimally InvasiveGynecologic Oncology

Pages
53–57
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As the Turkish Society of Minimally Invasive Gynecological Oncology, we present our consensus opinion and suggestions for the preoperative evaluation and morcellation of fibroids, in line with the recent literature. (J Turk Ger Gynecol Assoc 2021; 22: 53-7)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Morcellation allows the removal of a large uterus and fibroids through small incisions with minimally invasive surgery.
📊
Key Findings & Data:It helps to prevent the complications associated with large incisions in both hysterectomy and myomectomy operations.
💡
Conclusion & Impact:As the Turkish Society of Minimally Invasive Gynecological Oncology, we present our consensus opinion and suggestions for the preoperative evaluation and morcellation of fibroids, in line with the recent literature. (J Turk Ger Gynecol Assoc 2021; 22: 53-7)
🔬Design:Research Article
📍Scope:2021 Verileri
⚙️Variables:Domain Parameters

Abstract

Morcellation allows the removal of a large uterus and fibroids through small incisions with minimally invasive surgery. It helps to prevent the complications associated with large incisions in both hysterectomy and myomectomy operations. Currently, there is much debate regarding the use of power morcellation in laparoscopic hysterectomy and myomectomy, mainly due to the risk of peritoneal dissemination of undiagnosed uterine sarcomas. Unfortunately, there is no valid pre-operative diagnostic method that can differentiate sarcomas from myomas, and the currently available scientific literature regarding morcellation is insufficient. As the Turkish Society of Minimally Invasive Gynecological Oncology, we present our consensus opinion and suggestions for the preoperative evaluation and morcellation of fibroids, in line with the recent literature. (J Turk Ger Gynecol Assoc 2021; 22: 53-7)

🔖

Cite This Article

YALÇIN, İ., TAŞKIN, S., VARLI, B., ORTAÇ, F., TAŞKIRAN, Ç., GÜNGÖR, M. (2022). Morcellation in gynecology: short review andsuggestions from Turkish Society of Minimally InvasiveGynecologic Oncology. Journal of the Turkish-German Gynecological Association, Cilt: 22 - Sayı: 1, 53–57. https://ajindex.com/articles/567195

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Langenbeck CJM. Nosology and Therapy of Surgical Illnesses. Gottingen, Germany: 1845
  2. Semm K. Pelviscopy and Hysteroscopy: Color Atlas and Textbook. New York: Schattauer; 1976
  3. Mettler L, Semm K, Lehmann-Willenbrock L, Shah A, Shah P, Sharma R. Comparative evaluation of classical intrafascialsupracervical hysterectomy (CISH) with transuterine mucosal resection as performed by pelviscopy and laparotomy-our first 200 cases. Surg Endosc 1995; 9: 418-23
  4. Perri T, Korach J, Sadetzki S, Oberman B, Fridman E, Ben-Baruch G. Uterine leiomyosarcoma: does the primary surgical procedure matter? Int J Gynecol Cancer 2009; 19: 257-60
  5. Park JY, Park SK, Kim DY, Kim JH, Kim YM, Kim YT, et al. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma. Gynecol Oncol 2011; 122: 255-9
  6. US Food and Drug Administration. Laparoscopic Uterine Power Morcellation in Hysterectomy and Myomectomy: FDA Safety Communication, c.2104 Apr 17 (cited 2017 July 6) Available from:
  7. FDA UPDATED laparoscopic uterine power morcellation in hysterectomy and myomectomy: FDA safety communication FDA, 24 (2014, November) Retrieved from: http://www.fda. gov/MedicalDevices/Safety/AlertsandNotices/ucm424443.htm [13.09.15] 8. Halaska MJ, Haidopoulos D, Guyon F, Morice P, Zapardiel I, Kesic V, et al. European society of gynecological oncology statement on fibroid and uterine morcellation. Int J Gynecol Cancer 2017; 27: 189-92
  8. Brölmann H, Tanos V, Grimbizis G, Ind T, Philips K, van den Bosch T, et al. Options on fibroid morcellation: a literature review. Gynecol Surg 2015; 12: 3-15
  9. AAGL Advancing Minimally Invasive Gynecology Worldwide. AAGL practice report: morcellation during uterine tissue extraction. J Minim Invasive Gynecol 2014; 21: 517-30
  10. Beckmann MW, Juhasz-Böss I, Denschlag D, Gaß P, Dimpfl T, Harter P, et al. Surgical methods for the treatment of uterine fibroids - risk of uterine sarcoma and problems of morcellation: position paper of the DGGG. Geburtshilfe Frauenheilkd 2015; 75: 148-64
  11. Statement of the Society of Gynecologic Oncology to the Food and Drug Administration's Obstetrics and Gynecology Medical Devices Advisory Committee Concerning Safety of Laparoscopic Power Morcellation. SGO,2014, July. [13.09.15] Available from: https:// www.sgo.org/wp-content/uploads/2014/04/SGO-Testimony-toFDA-on-Power-Morcellation-FINAL.pdf 13. Rousse